Please login to the form below

Not currently logged in
Email:
Password:

Enerzair Breezhaler

This page shows the latest Enerzair Breezhaler news and features for those working in and with pharma, biotech and healthcare.

Novartis reveals full phase 3 results for Enerzair Breezhaler

Novartis reveals full phase 3 results for Enerzair Breezhaler

Asthma treatment received EU approval earlier this week. Novartis has published the full results from the phase 3 IRIDIUM study of its Enerzair Breezhaler in patients with uncontrolled asthma. ... The overall occurrence of adverse events and serious

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • On our best behaviour On our best behaviour

    Novartis entered a partnership with Propeller to utilise the company’s sensor for the Enerzair Breezhaler inhaler, where it can collect medication data and send that information to a corresponding app.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Thrive Agency

We are a specialist health communication agency creating powerful and trusted content. If you’re looking for a partner to help...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....